Supply Chain

Come September, all eyes will be on federal legislation that is close to final passage

Real business value arises from going beyond simple regulatory compliance for California's e-pedigree mandate

Broader quality management and more documentation of pharma logistics are the takeaways

International collaboration emerges as a focus

Next addition is 'already being planned' says divisional VP, Bill Hook

Proportion of cold chain products continues to grow in the biopharma inventory

Hangzhou, Shanghai and Sydney bring 325,000 sq. ft. of dedicated space to market

Next-gen SenseAware 2000 is deployed, along with a wider international distribution

The Movianto acquisition presages a new era for the company

Annual survey of leading third-party logistics providers tabulates their interest in serving manufacturers, hospitals and retail

Here are the factors to consider when deciding to use a third-party logistics provider (3PL)

This year's IQPC meeting - its 10th anniversary - promises to be the biggest yet

Dendreon's Provenge prostate-cancer treatment ramps up with unique supply chain complexities

Good design of vaults and cages for DEA-regulated materials calls for meeting regulatory requirements while accommodating operational practices

'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials

National organization proposes a draft standard; will hold workship in May

Purchase of Pieffe Group, combined with new facility launches, brings UPS capacity nearly to 5 million sq.ft. worldwide; more expected in 2012

New edition of 'The Role of Distributors,' plus a new report on specialty pharmaceutical distribution, highlight distributors’ roles in healthcare

Analysis combines financial and operational performance, and industry reputation, among manufacturers, distributors and healthcare systems

Rapidly rising healthcare-products trade is almost being matched by increased regulatory scrutiny

Specialty drug market success requires patient-focused and therapy-specific channel and services strategies